The torn ends of an ACL sit in joint fluid that dissolves the blood clot a wound needs to heal across, so a complete tear has traditionally meant reconstruction: the ligament is removed and replaced with a graft, usually tendon taken from elsewhere in the same knee.
The BEAR® Implant (Bridge-Enhanced ACL Restoration) is a resorbable collagen implant that the surgeon places between the torn ends of the ligament and loads with a small amount of the patient's own blood. The implant shields that clot from the joint fluid and gives the body's cells a bridge to grow across, so the ACL heals as one continuous ligament. Within about eight weeks the implant is absorbed and replaced by the patient's own cells, collagen and blood vessels, and the new tissue keeps remodeling and strengthening from there.
The implant's maker backs it with Level 1 clinical evidence. In its randomized trial, patients treated with the BEAR® Implant reported knee function at two years similar to reconstruction, their measured knee laxity at two years matched reconstruction, and their hamstring strength was statistically better at six and twelve months, a trend that held at two years. Those are the study's findings, not a promise about any one knee: the implant suits a specific range of tear patterns, and candidacy is decided from the tear, the tissue that remains and the time since injury, on MRI and in the exam room.
Reconstruction remains the right operation for many knees, and ACL surgery covers both paths in full. The BEAR® Implant videos in the Video Vault above, from the implant's maker, walk through the science, the procedure in the operating room and what a patient can expect; the vault's other groups cover the cartilage, meniscus, ankle, hip and orthobiologic work this page describes.